| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 2 securities · may seek to influence control | ||||||
|
Processa Pharmaceuticals, Inc.
13D/A
PCSA · 74275C403
|
13.0% |
2/23/2026
Event 2/13/2026
|
||||
|
Processa Pharmaceuticals, Inc.
13D/A
PCSA · 74275C304
|
10.9% |
10/15/2025
Event 8/5/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.